ClinicalTrials.gg
CompletedNCT00277901Updated Dec 2, 2014

MRI Assessment of RV Function: Patients With TOF or Aortic Coarctation

An observational study in Congenital Disorders, sponsored by Children's Healthcare of Atlanta. Completed at 1 site in United States. Open to participants aged Up to 21 Years. Per ClinicalTrials.gov, last updated 2014-12-02.

Primary conditionAortic CoarctationRegistry: Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesReclassifiedWhy we changed it
Registry
Congenital, Hereditary, and Neonatal Diseases and Abnormalities — the first condition term the registry derived for this study.
ClinicalTrials.gg
Aortic Coarctation
Why
  1. The study's title name Aortic Coarctation, a narrower term within Congenital, Hereditary, and Neonatal Diseases and Abnormalities.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Children's Healthcare of Atlanta · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
390
Ages
Up to 21 Years
Sex
All
01

Study summary

At Children's Healthcare of Atlanta at Egleston, it is standard of care to do a cardiac MRI on patients with the diagnosis of Tetralogy of Fallot and Aortic Coarctation to evaluate heart function. We propose to do a retrospective chart review of patient data along with their MRI data to analyze ventricular function and cavity volumes pre-Tetralogy of Fallot repair, post-Tetralogy of Fallot repair (pre-valve repair/replacement) and post-valve repair/replacement in order to assess the efficacy and optimal timing of valve replacement.

Read the detailed description

Patients with Tetralogy of Fallot have various degrees and levels of right ventricular outflow tract obstruction. They undergo surgical removal of the obstructing structures, which includes the pulmonary valve. The repair of the outflow tract is done utilizing a transannular patch. This approach, which is considered the standard of care, results in free pulmonary insufficiency, which may become severe and lead to right heart overloading and subsequent dilatation and dysfunction. This chronic overloading results in progressive tricuspid insufficiency and a suspected decline in effective pulmonary blood flow, cardiac output and right ventricle functional capabilities. Many patients develop progressive exercise intolerance, arrhythmias and severe cardiomegaly leading to dilated cardiomyopathy. The progressive decline in patient clinical status results in recommendations of pulmonary valve replacement to interrupt further dysfunction of the ventricles. Clinical improvement is generally seen among the patients and cardiac function is measurably improved in many cases, however the timing of surgery remains undefined and its impact on function improvement and recovery post -valve replacement is under serious debate and continuous discussion.

Preliminary work suggests that Magnetic Resonance Imaging (MRI) determined right to left ventricular volume ratio's of greater than 2:1 with associated tricuspid regurgitation, right ventricular regurgitant volumes of greater than 50%, and right ventricular ejection fractions less than 45% are common among patients with severe right ventricular failure and dysfunction. These patients are in need of pulmonary valve replacement and have routinely been referred for surgical intervention.

Patients with Aortic Coarctation have a localized malformation characterized by deformity of the aortic media, causing narrowing, usually severe, of the lumen of the vessel. Surgical repair or removal of this malformation is the treatment of choice however; the use of MRI to better determine the extent of damage or malformation would allow the surgeon to plan an operative strategy prior to opening the chest.

02

Conditions studied

  • Congenital Disorders

Browse trials for

Keywords

  • cardiac
  • pediatric
  • MRI
  • Tetralogy of Fallot TOF
  • Aortic Coarctation
03

In context

Aortic Coarctation Reclassified

49 studies on the registry are indexed under Aortic Coarctation; 16 are open to participants now.

This study's enrollment of 390 is above the median of 100 across 29 observational studies indexed under Aortic Coarctation.

Browse Aortic Coarctation studies →

Lead sponsor

Children's Healthcare of Atlanta is the lead sponsor of 97 studies on the registry; 6 are open to participants now.

Compared within Aortic Coarctation, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Congenital, Hereditary, and Neonatal Diseases and Abnormalities. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
Up to 21 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population is Patients with the diagnosis of Tetralogy of Fallot or Aortic Coarctation being Treated at Children's Healthcare of Atlanta at Egleston

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with the diagnosis of Tetralogy of Fallot or Aortic Coarctation being Treated at Children's Healthcare of Atlanta at Egleston.

Exclusion criteria

Exclusion Criteria:

  • Those patients who do not meet the inclusion criteria
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
390 participants (actual)
06

What researchers measure

Primary outcomes

  1. (1) Determine Right and left ventricular volumes during all phases of the cardiac cycle.

    (1) Determine Right and left ventricular volumes during all phases of the cardiac cycle.

    Time frame: 7 years

07

Study locations

1 site
  • Children's Healthcare of Atlanta
    Atlanta, Georgia 30322, United States
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Mar 2002, a primary completion of Jul 2009 and a completion of Jul 2009. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 13, 2006
First posted
Jan 18, 2006
Start
Mar 2002
Primary completionActual
Jul 2009
CompletionActual
Jul 2009
Last update
Dec 2, 2014
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 2, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00277901
Lead sponsor
Children's Healthcare of Atlanta
First posted
Jan 18, 2006
Start date
Mar 2002
Primary completion
Jul 2009
Completion
Jul 2009
Last update
Dec 2, 2014

Study contacts

James Parks, MD
principal investigator · Children's Healthcare of Atlanta, Sibley Heart Center Cardiology

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion